Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BELDEN INC. Director's Dealing 2025

Dec 8, 2025

31053_dirs_2025-12-08_cd53547e-4006-4ce7-b9c3-b9fcbe36e27a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2025-12-04

Reporting Person: Lieser Brian (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-04 Common Stock M 2516 $53.79 Acquired 31590 Direct
2025-12-04 Common Stock D 1759 $120.695 Disposed 29831 Direct
2025-12-04 Common Stock M 1210 $74.91 Acquired 31041 Direct
2025-12-04 Common Stock D 961 $120.695 Disposed 30080 Direct
2025-12-04 Common Stock M 1225 $72.73 Acquired 31305 Direct
2025-12-04 Common Stock D 961 $120.695 Disposed 30344 Direct
2025-12-05 Common Stock S 1270 $120 Disposed 29074 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-04 Stock Appreciation Rights $74.91 M 1210 Disposed 2027-02-22 Common Stock (1210) Direct
2025-12-04 Stock Appreciation Rights $72.73 M 1225 Disposed 2028-02-28 Common Stock (1225) Direct
2025-12-04 Stock Appreciation Rights $53.79 M 2516 Disposed 2032-02-22 Common Stock (2516) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 505.1454 Indirect

Footnotes

F1: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.

F2: Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.

F3: This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

F4: This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

F5: This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

F6: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.

F7: The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.